NM_001127511.3(APC):c.-134_-133insGGG AND Familial adenomatous polyposis 1

delete

Germline classification:: Likely benign (1 submission)
Last evaluated:: Jul 17, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002234238.15

Allele description

NM_001127511.3(APC):c.-134_-133insGGG

Gene:

APC:APC regulator of WNT signaling pathway [Gene - OMIM - HGNC]

Variant type:

Insertion

Cytogenetic location:

5q22.2

Genomic location:

Preferred name:

NM_001127511.3(APC):c.-134_-133insGGG

HGVS:

NC_000005.10:g.112707584_112707585insGGG
NG_008481.4:g.20064_20065insGGG
NG_173817.1:g.207_208insGGG
NM_001127511.3:c.-134_-133insGGG
NM_001354895.2:c.-317_-316insGGG
NM_001354897.2:c.-134_-133insGGG
NM_001354902.2:c.-134_-133insGGG
NM_001407446.1:c.-134_-133insGGG
NM_001407447.1:c.-317_-316insGGG
NM_001407448.1:c.-84_-83insGGG
NM_001407450.1:c.-84_-83insGGG
NM_001407452.1:c.-317_-316insGGG
NM_001407453.1:c.-108_-107insGGG
NM_001407456.1:c.-317_-316insGGG
NM_001407457.1:c.-84_-83insGGG
NM_001407458.1:c.-84_-83insGGG
NM_001407460.1:c.-317_-316insGGG
NM_001407469.1:c.-317_-316insGGG
NM_001407470.1:c.-1352_-1351insGGG
NM_001407472.1:c.-1352_-1351insGGG
LRG_130t3:c.-317_-316insGGG
LRG_130:g.20064_20065insGGG
NC_000005.9:g.112043281_112043282insGGG
NM_000038.5:c.-30360_-30359insGGG
NM_001127511.1:c.-317_-316insGGG
NR_176365.1:n.87_88insGGG
NR_176366.1:n.87_88insGGG

Links:

dbSNP: rs1561393341

NCBI 1000 Genomes Browser:

rs1561393341

Molecular consequence:

NM_001127511.3:c.-134_-133insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001354895.2:c.-317_-316insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001354897.2:c.-134_-133insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001354902.2:c.-134_-133insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407446.1:c.-134_-133insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407447.1:c.-317_-316insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407448.1:c.-84_-83insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407450.1:c.-84_-83insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407452.1:c.-317_-316insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407453.1:c.-108_-107insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407456.1:c.-317_-316insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407457.1:c.-84_-83insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407458.1:c.-84_-83insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407460.1:c.-317_-316insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407469.1:c.-317_-316insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407470.1:c.-1352_-1351insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001407472.1:c.-1352_-1351insGGG - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NR_176365.1:n.87_88insGGG - non-coding transcript variant - [Sequence Ontology: SO:0001619]
NR_176366.1:n.87_88insGGG - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Familial adenomatous polyposis 1 (FAP1)
Synonyms:: POLYPOSIS, ADENOMATOUS INTESTINAL; FAMILIAL ADENOMATOUS POLYPOSIS 1, ATTENUATED; APC-Associated Polyposis Conditions
Identifiers:: MONDO: MONDO:0021056; MedGen: C2713442; OMIM: 175100

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV000933994	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Likely benign (Jul 17, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV000933994

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Likely benign
(Jul 17, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Invitae, SCV000933994.7

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Jun 2, 2024

ClinVar

Relating variation to medicine